|
Class 2 Device Recall Clinical Innovations |
|
Date Initiated by Firm |
December 30, 2014 |
Date Posted |
January 27, 2015 |
Recall Status1 |
Terminated 3 on December 28, 2015 |
Recall Number |
Z-1014-2015 |
Recall Event ID |
70137 |
Product Classification |
Intrauterine tamponade balloon - Product Code OQY
|
Product |
Ebb Complete Tamponade System, BD-OTS Obstetric Catheter, REF CTS-1000, Rx Only, Sterile EO |
Code Information |
Lots: 0314-F-566; 0814-F-100; 0814-F-108; 0814-V-068 |
Recalling Firm/ Manufacturer |
Clinical Innovations, LLC 747 W 4170 S Murray UT 84123-1364
|
For Additional Information Contact |
Tom Haueter 801-268-8200
|
Manufacturer Reason for Recall |
Potential for a balloon leak in all lots of (CTS-1000) manufactured since August 2014.
|
FDA Determined Cause 2 |
Process design |
Action |
Clinical Innovations sent an "Urgent - Medical Device Recall" letter dated December 31, 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer.
They will be instructed to quarantine remaining product. A company representative will visit the hospital and retrieve the product in accordance to instructions detailed on the Representative Recall Reconciliation Instructions. The representative will reconcile the inventory on the Field Reconciliation Form and return the product to Clinical Innovations as indicated on the instructions. The address for the devices to be returned is included on the Representative Recall Reconciliation Instruct
Clinical Innovations is working diligently to resolve this issue. In the meantime ,please quarantine any remaining product in your hospital. A company representative will contact you and make arrangements for the return of the product. Clinical Innovations will provide replacement product as soon as it becomes available. If you have any questions,call Clinical Innovations,at 1-(888)268-6222 or your service representative, as is the name of the Company Contact. |
Quantity in Commerce |
827 units |
Distribution |
Worldwide Distribution - USA (nationwide) and the countries of : Canada, Finland, Estonia, Belgium, Ireland, Sweden, France, Switzerland, Spain, Netherlands, Middle East, Scotland, Germany and Wales. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|